Insufficient scRNA-seq data for expression of FATE1 at single-cell level.
Insufficient scRNA-seq data for expression of FATE1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 94% | 18.89 | 84 / 89 | 61% | 3.79 | 547 / 901 |
adrenal gland | 76% | 14.99 | 195 / 258 | 63% | 149.61 | 144 / 230 |
thymus | 89% | 32.14 | 578 / 653 | 44% | 1.57 | 264 / 605 |
lung | 62% | 9.75 | 360 / 578 | 26% | 0.62 | 302 / 1155 |
heart | 74% | 13.82 | 634 / 861 | 0% | 0 | 0 / 0 |
adipose | 69% | 13.28 | 831 / 1204 | 0% | 0 | 0 / 0 |
breast | 59% | 10.79 | 269 / 459 | 9% | 0.86 | 102 / 1118 |
muscle | 63% | 8.01 | 508 / 803 | 0% | 0 | 0 / 0 |
bladder | 52% | 4.19 | 11 / 21 | 9% | 0.21 | 45 / 504 |
uterus | 37% | 5.14 | 63 / 170 | 20% | 1.46 | 94 / 459 |
ovary | 46% | 3.29 | 82 / 180 | 11% | 0.29 | 48 / 430 |
prostate | 54% | 13.68 | 133 / 245 | 1% | 0.01 | 5 / 502 |
skin | 29% | 3.00 | 527 / 1809 | 26% | 0.50 | 123 / 472 |
intestine | 46% | 4.60 | 446 / 966 | 9% | 0.20 | 45 / 527 |
liver | 16% | 3.18 | 36 / 226 | 38% | 0.91 | 153 / 406 |
spleen | 49% | 4.33 | 117 / 241 | 0% | 0 | 0 / 0 |
brain | 41% | 9.51 | 1095 / 2642 | 7% | 0.23 | 47 / 705 |
esophagus | 45% | 4.95 | 656 / 1445 | 2% | 0.04 | 4 / 183 |
stomach | 38% | 2.95 | 137 / 359 | 8% | 0.14 | 24 / 286 |
pancreas | 30% | 2.07 | 97 / 328 | 8% | 0.16 | 14 / 178 |
lymph node | 0% | 0 | 0 / 0 | 34% | 0.63 | 10 / 29 |
tonsil | 0% | 0 | 0 / 0 | 33% | 2.45 | 15 / 45 |
blood vessel | 33% | 3.44 | 434 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 15% | 0.24 | 12 / 80 |
peripheral blood | 9% | 0.65 | 88 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006915 | Biological process | apoptotic process |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0051562 | Biological process | negative regulation of mitochondrial calcium ion concentration |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0044233 | Cellular component | mitochondria-associated endoplasmic reticulum membrane contact site |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0042802 | Molecular function | identical protein binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0005515 | Molecular function | protein binding |
Gene name | FATE1 |
Protein name | Fetal and adult testis-expressed transcript protein (Cancer/testis antigen 43) (CT43) (Tumor antigen BJ-HCC-2) Fetal and adult testis expressed 1 |
Synonyms | FATE |
Description | FUNCTION: Involved in the regulation of endoplasmic reticulum (ER)-mitochondria coupling. Negatively regulates the ER-mitochondria distance and Ca(2+) transfer from ER to mitochondria possibly implicating it in the regulation of apoptosis . May collaborate with RNF183 to restrain BIK protein levels thus regulating apoptotic signaling . . |
Accessions | H7C1I5 Q969F0 ENST00000370350.7 ENST00000417321.1 |